Abstract A15: In vivo efficacy of a CD38-specific engineered toxin body
Robinson, Garrett L., Rajagopalan, Sangeetha, Brieschke, Brigitte, Erdman, Jennifer, Neill, Jane, Flores, Rodney, Foree, Julia, Null, William, Liu, Jensing, Higgins, Jack P., Willert, Erin K.
Published in Clinical cancer research (01.09.2015)
Published in Clinical cancer research (01.09.2015)
Get full text
Journal Article
Abstract 2477: Engineered toxin bodies: A next-generation immunotoxin scaffold with novel immuno-oncology functionality
Willert, Erin K., Robinson, Garrett L., Rajagopalan, Sangeetha, Brieschke, Brigitte, Erdman, Jennifer, Neill, Jane, Flores, Rodney, Foree, Julia, Null, William, Liu, Jensing, Higgins, Jack P.
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
Abstract 1483: MT-3724, an engineered toxin body targeting CD20 for non-Hodgkin's lymphoma
Robinson, Garrett L., Rajagopalan, Sangeetha, Brieschke, Brigitte, Erdman, Jennifer, Neill, Jane, Flores-Lefranc, Rodney E., Foree, Julia, Null, William, Liu, Jensing, Higgins, Jack P., Willert, Erin K.
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article